-
-
-
-
-
-
-
Praxis Precision Medicines to Report Fourth Quarter and Full Year 2025 Financial Results on Thursday, February 19, 2026, and Participate in Upcoming Investor Conferences
-
-
-
-
-
-
-
Praxis Precision Medicines Announces Positive, Best-in-Disease Topline Results in Patients with Focal Onset Seizures from the RADIANT Study of Vormatrigine
-
-
-
-
-
-
-
Praxis Precision Medicines Provides Update on Essential3 and Corporate Update
-
-
-
-
-
-
-
Praxis Precision Medicines Provides Corporate Update and Reports Second Quarter 2024 Financial Results
-
-
-
-
-
-
-
Praxis Precision Medicines Provides Corporate Update and Reports Third Quarter 2023 Financial Results
-
-
-
-
-
-
-
Praxis Precision Medicines to Provide Corporate Update and Report First Quarter 2022 Financial Results on Monday, May 9, 2022
-
-
-
-
-
-
-
Aeglea BioTherapeutics (AGLE) Appoints Marcio Souza to Board of Directors
-
1,201,787 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

